B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma

Scott E. Strome, Haidong Dong, Hideto Tamura, Stephen G. Voss, Dallas B. Flies, Koji Tamada, Diva Salomao, John Cheville, Fumiya Hirano, Wei Lin, Jan L. Kasperbauer, Karla V. Ballman, Lieping Chen

Research output: Contribution to journalArticle

Abstract

In this report, we demonstrate that B7-H1, a B7 family molecule implicated in tumor immune evasion, is constitutively expressed on 66% of freshly isolated squamous cell carcinomas of the head and neck (SCCHN). To define the potential impact of tumor-associated B7-H1 on immunotherapy, the B7-H1-negative mouse SCC line, SCCVII, was transfected to express B7-H1. Although all of the animals succumbed to B7-H1/SCCVII tumors even after adoptive T-cell immunotherapy, the infusion of B7-H1 blocking monoclonal antibody with activated T cells cured 60% of animals. These data support B7-H1 blockade as a new approach to enhance the efficacy of T-cell immunotherapy.

Original languageEnglish (US)
Pages (from-to)6501-6505
Number of pages5
JournalCancer Research
Volume63
Issue number19
StatePublished - Oct 1 2003
Externally publishedYes

Fingerprint

Immunotherapy
Squamous Cell Carcinoma
T-Lymphocytes
B7 Antigens
Tumor Escape
Blocking Antibodies
Neoplasms
Monoclonal Antibodies
Carcinoma, squamous cell of head and neck

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Strome, S. E., Dong, H., Tamura, H., Voss, S. G., Flies, D. B., Tamada, K., ... Chen, L. (2003). B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma. Cancer Research, 63(19), 6501-6505.

B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma. / Strome, Scott E.; Dong, Haidong; Tamura, Hideto; Voss, Stephen G.; Flies, Dallas B.; Tamada, Koji; Salomao, Diva; Cheville, John; Hirano, Fumiya; Lin, Wei; Kasperbauer, Jan L.; Ballman, Karla V.; Chen, Lieping.

In: Cancer Research, Vol. 63, No. 19, 01.10.2003, p. 6501-6505.

Research output: Contribution to journalArticle

Strome, SE, Dong, H, Tamura, H, Voss, SG, Flies, DB, Tamada, K, Salomao, D, Cheville, J, Hirano, F, Lin, W, Kasperbauer, JL, Ballman, KV & Chen, L 2003, 'B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma', Cancer Research, vol. 63, no. 19, pp. 6501-6505.
Strome SE, Dong H, Tamura H, Voss SG, Flies DB, Tamada K et al. B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma. Cancer Research. 2003 Oct 1;63(19):6501-6505.
Strome, Scott E. ; Dong, Haidong ; Tamura, Hideto ; Voss, Stephen G. ; Flies, Dallas B. ; Tamada, Koji ; Salomao, Diva ; Cheville, John ; Hirano, Fumiya ; Lin, Wei ; Kasperbauer, Jan L. ; Ballman, Karla V. ; Chen, Lieping. / B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma. In: Cancer Research. 2003 ; Vol. 63, No. 19. pp. 6501-6505.
@article{7d9c233ee3fe421f919f2af431aba442,
title = "B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma",
abstract = "In this report, we demonstrate that B7-H1, a B7 family molecule implicated in tumor immune evasion, is constitutively expressed on 66{\%} of freshly isolated squamous cell carcinomas of the head and neck (SCCHN). To define the potential impact of tumor-associated B7-H1 on immunotherapy, the B7-H1-negative mouse SCC line, SCCVII, was transfected to express B7-H1. Although all of the animals succumbed to B7-H1/SCCVII tumors even after adoptive T-cell immunotherapy, the infusion of B7-H1 blocking monoclonal antibody with activated T cells cured 60{\%} of animals. These data support B7-H1 blockade as a new approach to enhance the efficacy of T-cell immunotherapy.",
author = "Strome, {Scott E.} and Haidong Dong and Hideto Tamura and Voss, {Stephen G.} and Flies, {Dallas B.} and Koji Tamada and Diva Salomao and John Cheville and Fumiya Hirano and Wei Lin and Kasperbauer, {Jan L.} and Ballman, {Karla V.} and Lieping Chen",
year = "2003",
month = "10",
day = "1",
language = "English (US)",
volume = "63",
pages = "6501--6505",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "19",

}

TY - JOUR

T1 - B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma

AU - Strome, Scott E.

AU - Dong, Haidong

AU - Tamura, Hideto

AU - Voss, Stephen G.

AU - Flies, Dallas B.

AU - Tamada, Koji

AU - Salomao, Diva

AU - Cheville, John

AU - Hirano, Fumiya

AU - Lin, Wei

AU - Kasperbauer, Jan L.

AU - Ballman, Karla V.

AU - Chen, Lieping

PY - 2003/10/1

Y1 - 2003/10/1

N2 - In this report, we demonstrate that B7-H1, a B7 family molecule implicated in tumor immune evasion, is constitutively expressed on 66% of freshly isolated squamous cell carcinomas of the head and neck (SCCHN). To define the potential impact of tumor-associated B7-H1 on immunotherapy, the B7-H1-negative mouse SCC line, SCCVII, was transfected to express B7-H1. Although all of the animals succumbed to B7-H1/SCCVII tumors even after adoptive T-cell immunotherapy, the infusion of B7-H1 blocking monoclonal antibody with activated T cells cured 60% of animals. These data support B7-H1 blockade as a new approach to enhance the efficacy of T-cell immunotherapy.

AB - In this report, we demonstrate that B7-H1, a B7 family molecule implicated in tumor immune evasion, is constitutively expressed on 66% of freshly isolated squamous cell carcinomas of the head and neck (SCCHN). To define the potential impact of tumor-associated B7-H1 on immunotherapy, the B7-H1-negative mouse SCC line, SCCVII, was transfected to express B7-H1. Although all of the animals succumbed to B7-H1/SCCVII tumors even after adoptive T-cell immunotherapy, the infusion of B7-H1 blocking monoclonal antibody with activated T cells cured 60% of animals. These data support B7-H1 blockade as a new approach to enhance the efficacy of T-cell immunotherapy.

UR - http://www.scopus.com/inward/record.url?scp=0141953992&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141953992&partnerID=8YFLogxK

M3 - Article

VL - 63

SP - 6501

EP - 6505

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 19

ER -